| Investor Type | Firm |
| Type of Fund | VC |
Invenshure is a venture capital fund that focuses on building companies to enact global change. They specialize in transforming complex challenges into successful businesses by applying rigorous business strategies to the world's leading institutional intellectual property (IP).
With a very early-stage investment model, Invenshure aims to provide substantial returns to their investors while contributing to the betterment of society. They pride themselves on their in-house team of scientists and engineers who are adept at evolving original IP into thriving commercial entities.
Their proven expertise and extensive networks facilitate the process of translating scientific discoveries into marketable products and services, positioning Invenshure as a notable force in the venture capital landscape.
This unique strength is leveraged by their portfolio companies as a significant advantage. Invenshure also engages with leading global institutions and minds to nurture novel ideas and inventions, turning groundbreaking IP into impactful products and services. They maintain a portfolio of companies that they have built from the ground up, utilizing their lab facilities and expert team to accelerate growth and innovation.
Their website highlights various news and events that showcase the accomplishments and progression of their portfolio companies as well as the fund itself.
Invenshure is actively interested in fostering growth and development in the fields they invest in, as evidenced by their news section, which features significant achievements such as the overcoming of cancer resistance by a lead candidate from a portfolio company and the acquisition of Imbio to create a comprehensive cardiothoracic image analysis portfolio.
Furthermore, they express a strong willingness to collaborate with like-minded individuals and organizations that share their vision of creating transformative companies.









